Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$20,345,350
+$2,562,851 QoQ
Shares Held
56,184
+11.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#380
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ethic Inc. holds $332,739,634 across 14 Drug Manufacturers - General names. AMGN ranks #6 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,920 | $109,052,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
358,041 | $46,008,268 | |
| 3 | JNJ |
Johnson & Johnson
|
109,758 | $27,875,239 | |
| 4 | PFE |
Pfizer Inc
|
882,175 | $21,242,774 | |
| 5 | ABBV |
AbbVie Inc.
|
83,563 | $21,027,793 | |
| 6 | AMGN |
Amgen Inc
This page
|
56,184 | $20,345,350 | |
| 7 | NVS |
Novartis AG
|
108,784 | $17,048,628 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
270,904 | $15,609,488 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,345,350 | 56,184 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $17,782,499 | 50,540 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $15,079,826 | 46,072 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $11,779,310 | 41,741 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $11,291,252 | 40,440 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $11,927,068 | 38,283 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $12,987,691 | 49,830 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,351,415 | 41,437 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,578,764 | 43,459 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,781,367 | 41,437 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $12,013,602 | 41,711 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,752,550 | 40,008 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,679,249 | 30,084 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,994,430 | 33,069 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,292,854 | 23,960 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,842,042 | 21,482 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,940,412 | 24,416 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $8,932,347 | 36,938 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,319,407 | 28,090 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,964,952 | 23,348 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,872,318 | 19,989 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,540,068 | 14,228 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,231,143 | 9,704 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,857,655 | 7,309 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,229,066 | 5,211 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $920,799 | 4,542 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||